Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$212K Sell
8,197
-3,565
-30% -$97.4K 0.37% 142
2017
Q4
$323K Sell
11,762
-3,799
-24% -$101K 0.47% 166
2017
Q3
$349K Buy
15,561
+1,947
+14% +$44K 0.49% 80
2017
Q2
$361K Sell
13,614
-1,431
-10% -$38.2K 0.48% 46
2017
Q1
$411K Buy
+15,045
New +$384K 0.38% 99
2016
Q3
Sell
-18,623
Closed -$352K 290
2016
Q2
$352K Buy
+18,623
New +$389K 0.29% 79
2015
Q2
Sell
-19,495
Closed -$475K 384
2015
Q1
$475K Sell
19,495
-1,106
-5% -$24.9K 0.24% 186
2014
Q4
$458K Buy
+20,601
New +$489K 0.2% 202

Other funds holding TBI

Lucus Advisors's TBI Position: Q1 2018 in Review

Lucus Advisors reduced its Trueblue (TBI) stake by 30% in Q1 2018, selling an estimated $97.4K and leaving 8,197 shares worth $212K. The position accounts for 0.37% of the portfolio, ranked #142.

Lucus Advisors first reported a position in TBI in Q4 2014 and has held it in 8 quarters since. The position peaked at $475K in Q1 2015. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

  • Lucus Advisors held 8,197 shares of Trueblue worth $212K as of Q1 2018.
  • Lucus Advisors sold 3,565 Trueblue shares in Q1 2018, an estimated $97.4K.
  • Trueblue made up 0.37% of Lucus Advisors's portfolio in Q1 2018, its #142 holding.
  • Lucus Advisors first reported a position in Trueblue in Q4 2014 and has held it in 8 quarters since.
  • Lucus Advisors's Trueblue position peaked at $475K in Q1 2015.
  • 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Lucus Advisors's 13F filing for Q1 2018, filed 15 May 2018.